TABLE 3.
Tests compared | Result for test A | No. with the following result for test B:
|
||
---|---|---|---|---|
Negative | Positive | Total | ||
Antibody (A) and leishmanin skin test (B) | Negative | 23 | 9 | 32 |
Positive | 14 | 13 | 27 | |
Total | 37 | 22 | 59 | |
Positive SI (A) and antibody (B) | Negative | 34 | 25 | 59 |
Positive | 15 | 4 | 19 | |
Total | 49 | 29 | 78 | |
Positive SI (A) and leishmanin skin test (B) | Negative | 36 | 14 | 50 |
Positive | 8 | 7 | 15 | |
Total | 44 | 21 | 65 |
There was no significant correlation between the antibody assay by DAT or immunofluorescence and the skin test response or a proliferative response index (as defined by an SI of ≥2).